From the microdosing boom to ketamine therapy, hallucinogens have experienced a boom in the last five years. During the COVID-19 lockdowns, research found that young people had been using psychedelics in place of drinking alcohol, with one in five experimenting with microdosing. It made sense that hallucinogens – which are often seen as ‘unsociable’ drugs – would have their moment in the sun at a time when pubs and clubs were closed and house parties resulted in £10,000 fines. But use of hallucinogens, which includes drugs such as LSD, magic mushrooms, 2C-B, DMT and ketamine, has only continued to increase since the pandemic, overtaking MDMA and ecstasy in the league table of most-used drugs. So what’s driving the trend?
It would be simple to suggest that the increase in hallucinogen use is a byproduct of young people staying at home. Research last year suggested that Gen Z was cutting back on clubbing in the face of the cost of living crisis, and one newspaper recently dubbed today’s youngsters “generation stay at home”. However, the majority of people who Dazed spoke to for this article say they use hallucinogens at raves, which suggests that it’s not that young people have stopped partying altogether, but instead that they’re partying differently.
For Becky, a 24-year-old student support worker living in Manchester, the switch from MDMA to 2C-B, a synthetic psychedelic drug which offers a mix of hallucinogenic and stimulant-like effects, was a no-brainer. “MDMA can make it hard to be around busy places, and actually makes me feel less sociable than 2C-B,” she tells Dazed. “But 2C-B makes music, lights and people more palatable and warmer.” She now uses 2C-B at every rave she goes to, which is about ten times a year. “I don’t do MDMA often at all now. I don’t enjoy it anymore, it just makes me anxious and stressed,” she adds.